MC
PMC

Menta Capital’s PharMerica Corporation PMC Stock Holding History

Menta Capital’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-25,800
Closed -$358K – 496
2013
Q2 		$358K Buy
+25,800
New +$366K 0.23% 180

Other funds holding PMC

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $167M AUM 20.81% 1-Year Est. Return

Menta Capital's PMC Position: Q3 2013 in Review

Menta Capital sold out of PharMerica Corporation (PMC) in Q3 2013, closing a stake of 25,800 shares — an estimated $358K sold.

Menta Capital first reported a position in PMC in Q2 2013 and held it in 1 quarter. The position peaked at $358K in Q2 2013. 147 funds tracked by Wall St. Rank hold PMC as of Q3 2013.

  • Menta Capital reported no remaining PharMerica Corporation position as of Q3 2013 after selling out during the quarter.
  • Menta Capital sold 25,800 PharMerica Corporation shares in Q3 2013, an estimated $358K.
  • Menta Capital first reported a position in PharMerica Corporation in Q2 2013 and held it in 1 quarter.
  • Menta Capital's PharMerica Corporation position peaked at $358K in Q2 2013.
  • 147 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2013.

Based on Menta Capital's 13F filing for Q3 2013, filed 5 Nov 2013.